Astellas oncology launch 2nd edition of c3 Prize

Do you have a bright idea to change cancer care?

For the second consecutive time, the Astellas Oncology C3 Prize® is calling for applicants from all over the world and from all backgrounds to submit their ideas for innovations to change cancer care. The C3 Prize, which aims to inspire and foster innovative, non-medical, non-treatment ideas, is offering $100,000 in unrestricted grants and access to mentorship to bring the brightest ideas to life. The Grand Prize Winner will receive a personal business consultation with Robert Herjavec, star of ABC’s Emmy Award-winning television show Shark Tank, technology entrepreneur and cancer caregiver. Each runner-up will receive a $12,500 grant from Astellas, and all the finalists will receive a one-year nights and weekends membership to MATTER, a healthcare innovation community.

Representing over 1,000 organisations, UICC believes there is a chance that talented staff from across its membership base might come up with the next big innovation in cancer care.

This is why we encourage you to apply for the C3 Prize if you have an idea that could improve the lives of cancer patients, their caregivers or their families.

Five finalists will be chosen for an exciting live pitch event hosted by UICC in Mexico City on 13 November 2017 during the World Cancer Leaders’ Summit.

Applications can be submitted starting on 19 June and will be accepted until 11:59 p.m. CST on 21 August 2017. The online application consists of answering three questions; a short, informal video is also strongly recommended, but not required.

Visit www.C3Prize.com to learn more on how to apply and receive additional information about the C3 Prize, including the full terms and conditions.

More Member Newsletter articles
17 May 2017

A First Look: Governments in Action on World Cancer Day

Governments are in a unique position to drive progress towards a healthier and brighter future for their nation. Read how a handful of governments led the way this World Cancer Day. 

Norwegian Cancer Society's AMR campaign
14 June 2017

Norwegian Cancer Society launch campaign on threat of antimicrobial resistance to cancer treatment

Wednesday, 14 June 2017 – Today, the Norwegian Cancer Society (NCS), have launched a new campaign calling on other organisations to raise awareness and take action against the threat of antimicrobial resistance (AMR) including antibiotic resistance, which could set cancer treatment back decades.

© Bristol-Myers Squibb | C2C4C ride
27 June 2017

Bristol-Myers Squibb employees raise funds for UICC members

The 2nd edition of the European Country 2 Country 4 Cancer ride organised by Bristol-Myers Squibb will take place in September supporting the Union for International Cancer Control and selected members to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.